Pre-vaccination evolution of antibodies among infants 0, 3 and 6Â months of age: A longitudinal analysis of measles, enterovirus 71 and coxsackievirus 16

Further modifications of vaccination strategies for measles, earlier vaccination for EV71 infection, and deployment of a CoxA16 vaccine need to be considered to limit infection among the very young.